Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halperin

Showing results (431-440 of 544) with videos related to

Pageof 55
Sort By:
The Pediatric Infectious Disease Journal|February 19, 2025
EPIDEMIOLOGY OF FEBRILE SEIZURES DURING THE COVID-19 PANDEMIC: A CANADIAN IMMUNIZATION MONITORING PROGRAM-ACTIVE (IMPACT) STUDYKarina A Top, Hennady P Shulha, Fahima Hassan, et al.
The Journal of Pediatrics|April 19, 2025
Influenza-Associated Mortality Among Children in Canada from 2004 to 2022Jennifer Tam, Jacqueline Modler, Julie A Bettinger, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 10, 2022
Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research NetworkSneha Suresh, Joseline Zafack, Anne Pham-Huy, et al.
The Pediatric Infectious Disease Journal|December 18, 2012
Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: a randomized, open-label studyBruce Tapiéro, Scott A Halperin, Mark Dionne, et al.
The Pediatric Infectious Disease Journal|December 4, 2023
Bloodstream Infections in Children Hospitalized for Influenza, the Canadian Immunization Monitoring Program ActiveJacqueline Modler, Shaun K Morris, Julie A Bettinger, et al.
Frontiers in Immunology|July 26, 2021
The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-AnalysisBahaa Abu-Raya, Kirsten Maertens, Flor M Munoz, et al.
The Journal of Infectious Diseases|September 11, 2019
Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy AdultsScott A Halperin, Rituparna Das, Matthew T Onorato, et al.
Nature Chemical Biology|July 19, 2011
Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer targetTing Chen, Duygu Ozel, Yuan Qiao, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 29, 2011
Immunogenicity of a half-dose of adjuvanted 2009 pandemic H1N1 influenza vaccine in adults: a prospective cohort studyB L Coleman, S P Kuster, J Gubbay, et al.
Circulation Research|January 10, 2009
Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complexGongxiong Wu, Weiguo Hu, Aliakbar Shahsafaei, et al.
Pageof 55

Showing results (431-440 of 544) with videos related to

Sort By:
Pageof 55
The Pediatric Infectious Disease Journal|February 19, 2025
EPIDEMIOLOGY OF FEBRILE SEIZURES DURING THE COVID-19 PANDEMIC: A CANADIAN IMMUNIZATION MONITORING PROGRAM-ACTIVE (IMPACT) STUDYKarina A Top, Hennady P Shulha, Fahima Hassan, et al.
The Journal of Pediatrics|April 19, 2025
Influenza-Associated Mortality Among Children in Canada from 2004 to 2022Jennifer Tam, Jacqueline Modler, Julie A Bettinger, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 10, 2022
Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research NetworkSneha Suresh, Joseline Zafack, Anne Pham-Huy, et al.
The Pediatric Infectious Disease Journal|December 18, 2012
Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: a randomized, open-label studyBruce Tapiéro, Scott A Halperin, Mark Dionne, et al.
The Pediatric Infectious Disease Journal|December 4, 2023
Bloodstream Infections in Children Hospitalized for Influenza, the Canadian Immunization Monitoring Program ActiveJacqueline Modler, Shaun K Morris, Julie A Bettinger, et al.
Frontiers in Immunology|July 26, 2021
The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-AnalysisBahaa Abu-Raya, Kirsten Maertens, Flor M Munoz, et al.
The Journal of Infectious Diseases|September 11, 2019
Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy AdultsScott A Halperin, Rituparna Das, Matthew T Onorato, et al.
Nature Chemical Biology|July 19, 2011
Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer targetTing Chen, Duygu Ozel, Yuan Qiao, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 29, 2011
Immunogenicity of a half-dose of adjuvanted 2009 pandemic H1N1 influenza vaccine in adults: a prospective cohort studyB L Coleman, S P Kuster, J Gubbay, et al.
Circulation Research|January 10, 2009
Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complexGongxiong Wu, Weiguo Hu, Aliakbar Shahsafaei, et al.
Pageof 55